Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GJ.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.103EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.103ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.103ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.103EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.103EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.103ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.103ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used